Arkolith/Insider Trading/SGMT/Form 4

Happel David

President & CEO, DirectorSagimet Biosciences Inc. (SGMT) · full profile →Form 4 · filed Dec 8, 2023
Net Buying
Open-Market Buys
$7K
Open-Market Sells
$0
Net Open-Market Flow
$7K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 7, 2023Buy(P)2K$4.10$7K627K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-124678) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML